Spots Global Cancer Trial Database for A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Official Title: Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated AL Amyloidosis
Study ID: NCT05652335
Interventions
Study Description
Brief Summary: The primary purpose of this study is to identify the recommended phase 2 dose (RP2D\[s\]) and schedule(s) to be safe for JNJ-79635322 in Part 1 (dose escalation), and to characterize the safety and tolerability of JNJ-79635322 at the RP2D(s) selected and in disease subgroups in Part 2 (dose expansion).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
City of Hope, Duarte, California, United States
City of Hope Orange County Lennar Foundation Cancer Center, Irvine, California, United States
Icahn School of Medicine at Mt. Sinai, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
UZ Antwerpen, Edegem, , Belgium
UZ Gent, Gent, , Belgium
CHU de Liege, Liege, , Belgium
CHU Nantes, Nantes, , France
CHU Lyon Sud, Pierre benite, , France
Chu Rennes Hopital Pontchaillou, Rennes, , France
Institut Claudius Regaud, Toulouse, , France
VUMC Amsterdam, Amsterdam, , Netherlands
UMC Utrecht, Utrecht, , Netherlands
Hosp. Univ. Germans Trias I Pujol, Badalona, , Spain
Hosp. Clinic de Barcelona, Barcelona, , Spain
Hosp. Univ. Fund. Jimenez Diaz, Madrid, , Spain
Clinica Univ. de Navarra, Pamplona, , Spain
Hosp. Clinico Univ. de Salamanca, Salamanca, , Spain
University College Hospital, London, , United Kingdom
Royal Marsden Hospital, Sutton, , United Kingdom
Contact Details
Name: Janssen Research & Development, LLC Clinical Trial
Affiliation: Janssen Research & Development, LLC
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
